Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-10

Clinical Trial Update: Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating human umbilical cord-derived mesenchymal stem cells for lupus nephritis; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Lingyun Sun | Conditions: Lupus Nephritis | Phase 2 | Status: UNKNOWN